Hypersensitivity Myocarditis and Hepatitis Associated with Imipramine and Its Metabolite, Desipramine
- 1 July 1989
- journal article
- case report
- Published by ASTM International in Journal of Forensic Sciences
- Vol. 34 (4) , 12732J-1020
- https://doi.org/10.1520/jfs12732j
Abstract
We present two cases of myocarditis and hepatitis with histologic characteristics of hypersensitivity-mediated drug reactions associated with imipramine and its metabolite, desipramine. In one case, death was directly attributed to myocarditis; in the second case, the patient died of an acute myocardial infarct, but myocarditis may have played a contributory role. One patient was taking imipramine, and therapeutic concentrations of imipramine and desipramine were documented in postmortem blood. The other patient was receiving desipramine documented by in-patient hospital medication records. Both cases had liver lesions associated in the medical literature with adverse drug reaction to imipramine.Keywords
This publication has 9 references indexed in Scilit:
- Myocarditis Related to Drug HypersensitivityMayo Clinic Proceedings, 1985
- Massive Eosinophilic Reaction to Desipramine in Conjunction with Pneumonia*The Canadian Journal of Psychiatry, 1984
- Desipramine-Associated HepatitisJournal of Clinical Psychopharmacology, 1983
- Diagnosis and Classification of Myocarditis by Endomyocardial BiopsyNew England Journal of Medicine, 1983
- Desipramine-Induced Pulmonary Interstitial EosinophiliaDrug Intelligence & Clinical Pharmacy, 1982
- Drug related myocarditisHuman Pathology, 1981
- Hepatic sensitivity to imipramineDigestive Diseases and Sciences, 1977
- Löffler's endocarditis and Davies' endomyocardial fibrosisAmerican Heart Journal, 1973
- Endomyocardial disease and eosinophilia: A clinical and pathologic spectrumThe American Journal of Medicine, 1969